Eli Lilly and Company (NYSE:LLY) has elected Mary Lynne Hedley as a new board member, starting May 15, 2022. Hedley will serve on the board committees related to science and technology, and ethics and compliance. Hedley is an immunologist and cancer cell biologist with substantial experience in the pharma industry. Hedley has worked as a…